US Animal Therapeutics and Diagnostics Market Size Study, by Product Type (Animal Diagnostics Products, Animal Therapeutics Products), by Animal Type (Companion Animals, Cattle, Pigs, Poultry, Sheep) Forecasts 2022-2032
US Animal Therapeutics and Diagnostics Market is valued at approximately USD 10.06 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.64 % over the forecast period 2024-2032. Animal Therapeutics and Diagnostics (ATD) in veterinary medicine focuses on developing medications, vaccines, supplements, and surgical techniques to enhance animal health and prevent diseases. It employs various diagnostic methods including laboratory tests, imaging, molecular diagnostics, point-of-care testing, and biosensors for accurate disease detection and monitoring. Animal Therapeutics and Diagnostics play a crucial role in ensuring animal welfare, preventing disease transmission to humans, maintaining food safety, and supporting agriculture and pet care industries. Advances in biotechnology, genomics, and medical technology continually improve diagnostic and treatment methods for animals. In the US, the Animal Therapeutics and Diagnostics (ATD) market is witnessing significant trends such as the demand for personalized veterinary care, leading to specialized therapeutics and diagnostics. There is also a growing focus on preventive healthcare, prompting innovation in vaccines and early disease detection tools. Integration of telemedicine and wearable devices further enhances care efficiency and remote monitoring capabilities, reshaping the industry to better meet the needs of veterinarians and pet owners.
The US Animal Therapeutics and Diagnostics market is propelled by increasing pet ownership rates driven by urbanization and a heightened focus on pet welfare, leading to greater demand for veterinary services and products. Technological advancements in veterinary medicine are fostering innovation, resulting in more effective treatments and diagnostics. Rising awareness of preventive care is driving the need for early disease detection solutions. Societal emphasis on animal health is elevating care standards and fueling demand for advanced therapeutics and diagnostics. Integration of telemedicine and wearable devices is improving care delivery efficiency. However, market growth is hampered by the high costs of veterinary treatments, deterring some owners from seeking necessary care. Regulatory hurdles in approving and commercializing animal health products also pose challenges. Additionally, the scarcity of skilled veterinarians, especially in rural areas, limits market expansion.
Major market player included in this report are:
IDEXX Laboratories, Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
VCA, Inc.
Heska Corporation
Covetrus, Inc.
Kindred Biosciences, Inc.
Animal Health International, Inc.
Patterson Companies, Inc.
Zoetis Inc
The detailed segments and sub-segments of the market are explained below:
By Product Type
Animal Diagnostics Products
Animal Therapeutics Products
By Animal Type
Companion Animals
Cattle
Pigs
Poultry
Sheep
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
The US Animal Therapeutics and Diagnostics market is propelled by increasing pet ownership rates driven by urbanization and a heightened focus on pet welfare, leading to greater demand for veterinary services and products. Technological advancements in veterinary medicine are fostering innovation, resulting in more effective treatments and diagnostics. Rising awareness of preventive care is driving the need for early disease detection solutions. Societal emphasis on animal health is elevating care standards and fueling demand for advanced therapeutics and diagnostics. Integration of telemedicine and wearable devices is improving care delivery efficiency. However, market growth is hampered by the high costs of veterinary treatments, deterring some owners from seeking necessary care. Regulatory hurdles in approving and commercializing animal health products also pose challenges. Additionally, the scarcity of skilled veterinarians, especially in rural areas, limits market expansion.
Major market player included in this report are:
IDEXX Laboratories, Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
VCA, Inc.
Heska Corporation
Covetrus, Inc.
Kindred Biosciences, Inc.
Animal Health International, Inc.
Patterson Companies, Inc.
Zoetis Inc
The detailed segments and sub-segments of the market are explained below:
By Product Type
Animal Diagnostics Products
Animal Therapeutics Products
By Animal Type
Companion Animals
Cattle
Pigs
Poultry
Sheep
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Animal Therapeutics and Diagnostics Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product Type
2.2.2. By Animal Type
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT TYPE 2022-2032
5.1. Animal Diagnostics Products
5.2. Animal Therapeutics Products
CHAPTER 6. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY ANIMAL TYPE 2022-2032
6.1. Companion Animals
6.2. Cattle
6.3. Pigs
6.4. Poultry
6.5. Sheep
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. IDEXX Laboratories, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Elanco Animal Health Incorporated
7.3.3. Merck & Co., Inc.
7.3.4. VCA, Inc.
7.3.5. Heska Corporation
7.3.6. Covetrus, Inc.
7.3.7. Kindred Biosciences, Inc.
7.3.8. Animal Health International, Inc.
7.3.9. Patterson Companies, Inc.
7.3.10. Zoetis Inc
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Animal Therapeutics and Diagnostics Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product Type
2.2.2. By Animal Type
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT TYPE 2022-2032
5.1. Animal Diagnostics Products
5.2. Animal Therapeutics Products
CHAPTER 6. US ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY ANIMAL TYPE 2022-2032
6.1. Companion Animals
6.2. Cattle
6.3. Pigs
6.4. Poultry
6.5. Sheep
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. IDEXX Laboratories, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Elanco Animal Health Incorporated
7.3.3. Merck & Co., Inc.
7.3.4. VCA, Inc.
7.3.5. Heska Corporation
7.3.6. Covetrus, Inc.
7.3.7. Kindred Biosciences, Inc.
7.3.8. Animal Health International, Inc.
7.3.9. Patterson Companies, Inc.
7.3.10. Zoetis Inc
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
LIST OF TABLES
TABLE 1. US Animal Therapeutics and Diagnostics market, report scope
TABLE 2. US Animal Therapeutics and Diagnostics market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 3. US Animal Therapeutics and Diagnostics market estimates & forecasts by Animal Type 2022-2032 (USD Billion)
TABLE 4. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 5. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 11. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 12. List of secondary sources, used in the study of US Animal Therapeutics and Diagnostics Market.
TABLE 13. List of primary sources, used in the study of US Animal Therapeutics and Diagnostics Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered.
TABLE 1. US Animal Therapeutics and Diagnostics market, report scope
TABLE 2. US Animal Therapeutics and Diagnostics market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 3. US Animal Therapeutics and Diagnostics market estimates & forecasts by Animal Type 2022-2032 (USD Billion)
TABLE 4. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 5. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. US Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 11. U.S. Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 12. List of secondary sources, used in the study of US Animal Therapeutics and Diagnostics Market.
TABLE 13. List of primary sources, used in the study of US Animal Therapeutics and Diagnostics Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered.
LIST OF FIGURES
FIG 1. US Animal Therapeutics and Diagnostics market, research methodology
FIG 2. US Animal Therapeutics and Diagnostics market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Animal Therapeutics and Diagnostics market, key trends 2023
FIG 5. US Animal Therapeutics and Diagnostics market, growth prospects 2022-2032
FIG 6. US Animal Therapeutics and Diagnostics market, porters 5 force model
FIG 7. US Animal Therapeutics and Diagnostics market, pestel analysis
FIG 8. US Animal Therapeutics and Diagnostics market, value chain analysis
FIG 9. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 10. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 11. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 12. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 13. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 14. US Animal Therapeutics and Diagnostics market, company market share analysis (2023)
FIG 1. US Animal Therapeutics and Diagnostics market, research methodology
FIG 2. US Animal Therapeutics and Diagnostics market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Animal Therapeutics and Diagnostics market, key trends 2023
FIG 5. US Animal Therapeutics and Diagnostics market, growth prospects 2022-2032
FIG 6. US Animal Therapeutics and Diagnostics market, porters 5 force model
FIG 7. US Animal Therapeutics and Diagnostics market, pestel analysis
FIG 8. US Animal Therapeutics and Diagnostics market, value chain analysis
FIG 9. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 10. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 11. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 12. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 13. US Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 14. US Animal Therapeutics and Diagnostics market, company market share analysis (2023)
